NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst®-Lung Liquid Biopsy Test
Press Release
Read More
NeoGenomics To Virtually Participate In 17th Annual Craig-Hallum Institutional Investor Conference
Press Release
Read More
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Literature
Read More
NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference
Press Release
Read More
Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study
Literature
Read More
NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients
Press Release
Read More
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
Press Release
Read More
NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
Press Release
Read More